Prognostic value of circulating cytokines for stage III colon cancer
Authors:
- 1 June 2013
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 182 (1) , 49-54
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mutations in K-ras and Epidermal Growth Factor Receptor Expression in Korean Patients With Stages III and IV Colorectal CancerInternational Journal of Surgical Pathology, 2011
- Nationwide Cancer Incidence in Korea, 2003-2005Cancer Research and Treatment, 2009
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and IIIBritish Journal of Cancer, 2001
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- National Surgical Adjuvant Breast and Bowel Project trials in colon cancerSeminars in Oncology, 2001
- Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal CancersJNCI: Journal of the National Cancer Institute, 1999
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCERThe Lancet, 1987